Atogepant prevents acute headaches in adults with chronic migraines

Question clinique

Is atogepant (Qulipta) effective in reducing headache frequency in adults with chronic migraines?

L’Essentiel

Atogepant is more effective than placebo in preventing acute migraines in highly selected adults with chronic migraine. While it is unclear if atogepant is any better than other preventive therapies, it is certainly more expensive. 1b

Plan de l'etude: Randomized controlled trial (double-blinded)

Financement: Industry

Cadre: Outpatient (specialty)

Reviewer

Henry C. Barry, MD, MS
Professor
Michigan State University
East Lansing, MI


Discutez de ce POEM


Commentaires

ARUP KUMAR DHARA

Impact assessment

Excellent